Dec 2020 $9 M No. 6 $2 to $10 million 3
CoDa Therapeutics Inc: Raise no. 6, Dec 2020 × Investors in this round 3 investors had bought by the notice of Jan 13, 2021: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Levy · Executive Officer, Director David Pool · Executive Officer James Blair · Director Pavel Rodyukov · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amounts paid pursuant to conversion of indebtedness.”Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 13, 2021. Read the notice at the SEC .
equity SEC Jun 2015 $1 M No. 5 Under $2 million 2
CoDa Therapeutics Inc: Raise no. 5, Jun 2015 × Investors in this round 2 investors had bought by the notice of Jun 15, 2015: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bradford Duft · Executive Officer, Director David Pool · Executive Officer "Howard ""Ted""" Greene · Director Geoff Brooke · Director Inna Martin Eitan · Director James Blair · Director James Mervis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount includes estimated amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's preferred stock (assuming no net issue exercise, where applicable). The warrants have not yet been exercised.”Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 15, 2015. Read the notice at the SEC .
debt, options SEC Feb 2015 $1 M No. 4 Under $2 million 2
CoDa Therapeutics Inc: Raise no. 4, Feb 2015 × Investors in this round 2 investors had bought by the notice of Feb 19, 2015: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bradford Duft · Executive Officer, Director David Pool · Executive Officer "Howard ""Ted""" Greene · Director Geoff Brooke · Director James Blair · Director James Mervis · Director Mikhail Getman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount includes estimated amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's preferred stock (assuming no net issue exercise, where applicable). The warrants have not yet been exercised.”Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 19, 2015. Read the notice at the SEC .
debt, options SEC May 2014 $3 M No. 3 $2 to $10 million 2
CoDa Therapeutics Inc: Raise no. 3, May 2014 × Investors in this round 2 investors had bought by the notice of Jun 10, 2014: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $6 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bradford Duft · Executive Officer, Director David Pool · Executive Officer "Howard ""Ted""" Greene · Director Anton Gopka · Director Geoff Brooke · Director James Blair · Director James Mervis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount includes estimated amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's preferred stock (assuming no net issue exercise, where applicable). The warrants have not yet been exercised.”Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 10, 2014. Read the notice at the SEC .
debt, options SEC Jul 2012 $19 M No. 2 $10 to $50 million 1
CoDa Therapeutics Inc: Raise no. 2, Jul 2012 × Investors in this round 1 investor had bought by the notice of Aug 1, 2012: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $19 M of $19 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bradford Duft · Executive Officer, Director David Pool · Executive Officer "Howard ""Ted""" Greene · Director Anton Gopka · Director Geoff Brooke · Director James Blair · Director James Mervis · Director Peter Thompson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 1, 2012. Read the notice at the SEC .
equity SEC Apr 2011 $19 M No. 1 $10 to $50 million 4
CoDa Therapeutics Inc: Raise no. 1, Apr 2011 × Investors in this round 4 investors had bought by the notice of May 13, 2011: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $19 M of $35 M offered; $16 M still to sell
Smallest investment taken $100,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $2,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bradford Duft · Executive Officer, Director David Pool · Executive Officer Colin Green · Director Geoff Brooke · Director Howard Greene, Jr. · Director James Blair · Director James Mervis · Director Peter Thompson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Pool, Chief Financial Officer. Source: SEC Form D, newest notice filed May 13, 2011. Read the notice at the SEC .
equity SEC